|Articles|October 14, 2014

Showing Patients the Bigger Mobile Health Picture

Author(s)Guest Blogger

To understand just how far mobile and digital technology can truly influence progress in global healthcare, we first need to form the foundation of the discussion with a few rudimentary facts.

To understand just how far mobile and digital technology can truly influence progress in global healthcare, we first need to form the foundation of the discussion with a few rudimentary facts.

  • Clinical research (“a branch of medical science in human beings”) is critical to healthcare.

  • All patients are human beings.

  • All stakeholders are current or potential patients.

  • All stakeholders therefore have a vested interest in progression of healthcare.

Our current healthcare model is evolving, slowly but surely. How this progression is defined, and how mobile and digital technology can help to speed this along, is explored in this Applied Clinical Trials article by Judith Teall.


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.